The promise, problems and pitfalls of mass drug administration for malaria elimination: A qualitative study with scientists and policymakers

International Health

Volumn 11, Issue 3, 2019, Pages 166-176

  Kaehler, Nils ^a,b   Adhikari, Bipin ^b,c   Cheah, Phaik Yeong ^b,c,d   Day, Nicholas P J ^b,c   Paris, Daniel H ^a   Tanner, Marcel ^a   Pell, Christopher ^e,f  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Community engagement; elimination; governance; malaria control; policy

Indexed keywords

ANTIMALARIAL AGENT;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; ATTITUDE TO ILLNESS; AUSTRALIA; COMMUNITY PARTICIPATION; EVIDENCE BASED MEDICINE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH PERSONNEL ATTITUDE; HUMAN; INTERVIEW; MALARIA; MALARIA CONTROL; MASS DRUG ADMINISTRATION; PARASITE CLEARANCE; PILOT STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; PROGRAM EFFECTIVENESS; QUALITATIVE RESEARCH; SCIENTIST; SEMI STRUCTURED INTERVIEW; WORLD HEALTH ORGANIZATION; ADMINISTRATIVE PERSONNEL; DISEASE ERADICATION; DRUG RESISTANCE; PERSONNEL; PROCEDURES; PSYCHOLOGY;

ADMINISTRATIVE PERSONNEL; ANTIMALARIALS; AUSTRALIA; DISEASE ERADICATION; DRUG RESISTANCE; HUMANS; MALARIA; MASS DRUG ADMINISTRATION; QUALITATIVE RESEARCH; RESEARCH PERSONNEL;

EID: 85064824373     PISSN: 18763413     EISSN: 18763405     Source Type: Journal    
DOI: 10.1093/inthealth/ihy079     Document Type: Article

References (39)

1. Von Seidlein L, Dondorp A. Fighting fire with fire: Mass antimalarial drug administrations in an era of antimalarial resistance. Expert Rev Anti Infect Ther. 2015;13(6):715-30.
2. Peters W. Chemotherapy and drug resistance in malaria. Vol. 1. New York: Academic Press; 1987.
3. Bjorkman A, Phillips-Howard PA. The epidemiology of drug-resistant malaria. Trans R Soc Trop Med Hyg. 1990;84(2):177-80.
4. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, et al. Epidemiology of drug-resistant malaria. Lancet Infect Dis. 2002;2(4):209-18.
5. Looareesuwan S, Viravan C, Webster HK, et al. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg. 1996;54(1):62-6.
6. Noedl H, Se Y, Schaecher K, et al. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359(24):2619-20.
7. Ashley EA, Dhorda M, Fairhurst RM, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371(5): 411-23.
8. Mbengue A, Bhattacharjee S, Pandharkar T, et al. A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. Nature. 2015;520(7549):683-7.
9. World Health Organization. Accelerating malaria elimination in the Greater Mekong Subregion. http://www.who.int/malaria/areas/greater-mekong/overview/en/(accessed 23 May 2018).
10. World Health Organization. Strategy for malaria elimination in the Greater Mekong Subregion (2015-2030). Geneva: World Health Organization; 2015.
11. Imwong M, Suwannasin K, Kunasol C, et al. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: A molecular epidemiology observational study. Lancet Infect Dis. 2017;17(5):491-7.
12. Landier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisininresistant falciparum malaria: A pilot trial in four villages of eastern Myanmar. Wellcome Open Res. 2017;2:81.
13. Tripura R, Peto TJ, Nguon C, et al. A controlled trial of mass drug administration to interrupt transmission of multidrug-resistant falciparum malaria in Cambodian villages. Clin Infect Dis. 2018;67(6): 817-26.
14. Landier J, Parker DM, Thu AM, et al. Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in eastern Myanmar: An observational study of a regional elimination programme. Lancet. 2018;391(10133):1916-26.
15. Chan XHS, Win YN, Mawer LJ, et al. Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: A systematic review and Bayesian meta-analysis. Lancet Infect Dis. 2018;18(8): 913-23.
16. Adhikari B, James N, Newby G, et al. Community engagement and population coverage in mass anti-malarial administrations: A systematic literature review. Malar J. 2016;15(1):523.
17. Hotez PJ. Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases. Clin Pharmacol Ther. 2009;85(6):659-64.
18. Lubell Y, White L, Varadan S, et al. Ethics, economics, and the use of primaquine to reduce falciparum malaria transmission in asymptomatic populations. PLoS Med. 2014;11(8):e1001704.
19. Newby G, Hwang J, Koita K, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015;93(1):125-34.
20. Cheah PY, White NJ. Antimalarial mass drug administration: Ethical considerations. Int Health. 2016;8(4):235-8.
21. Poirot E, Skarbinski J, Sinclair D, et al. Mass drug administration for malaria. Cochrane Database Syst Rev. 2013;12:CD008846.
22. Pell C, Tripura R, Nguon C, et al. Mass anti-malarial administration in western Cambodia: A qualitative study of factors affecting coverage. Malar J. 2017;16(1):206.
23. Peto TJ, Tripura R, Davoeung C, et al. Reflections on a community engagement strategy for mass antimalarial drug administration in Cambodia. Am J Trop Med Hyg. 2018;98(1):100-4.
24. Peto TJ, Tripura R, Sanann N, et al. The feasibility and acceptability of mass drug administration for malaria in Cambodia: A mixed-methods study. Trans R Soc Trop Med Hyg. 2018;112(6): 264-71.
25. Adhikari B, Pell C, Phommasone K, et al. Elements of effective community engagement: Lessons from a targeted malaria elimination study in Lao PDR (Laos). Glob Health Action. 2017;10(1): 1366136.
26. Adhikari B, Phommasone K, Kommarasy P, et al. Why do people participate in mass anti-malarial administration Findings from a qualitative study in Nong District, Savannakhet Province, Lao PDR (Laos). Malar J. 2018;17(1):15.
27. Adhikari B, Phommasone K, Pongvongsa T, et al. Factors associated with population coverage of targeted malaria elimination (TME) in southern Savannakhet Province, Lao PDR. Malar J. 2017; 16(1):424.
28. Kajeechiwa L, Thwin MM, Nosten S, et al. Community engagement for the rapid elimination of malaria: The case of Kayin State, Myanmar. Wellcome Open Res. 2017;2:59.
29. Kajeechiwa L, Thwin MM, Shee PW, et al. The acceptability of mass administrations of anti-malarial drugs as part of targeted malaria elimination in villages along the Thai-Myanmar border. Malar J. 2016;15(1):494.
30. Nguyen TN, Thu PN, Hung NT, et al. Community perceptions of targeted anti-malarial mass drug administrations in two provinces in Vietnam: A quantitative survey. Malar J. 2017;16(1):17.
31. Glasser B, Strauss A. The discovery of grounded theory: Strategies for qualitative research. New York: Aldine; 1967.
32. Atkinson JA, Vallely A, Fitzgerald L, et al. The architecture and effect of participation: A systematic review of community participation for communicable disease control and elimination. Implications for malaria elimination. Malar J. 2011;10:225.
33. Global Malaria Programme. The role of mass drug administration, mass screening and treatment, and focal screening and treatment for malaria. Geneva: World Health Organization; 2015.
34. Malaria Policy Advisory Committee. Mass drug administration, mass screening and treatment and focal screening and treatment for malaria. Malaria Policy Advisory Committee Meeting, 16-18 September 2015. Geneva: World Health Organization; 2015.
35. Sahan K, Pell C, Smithuis F, et al. Community engagement and the social context of targeted malaria treatment: A qualitative study in Kayin (Karen) State, Myanmar. Malar J. 2017;16(1):75.
36. Parker DM, Carrara VI, Pukrittayakamee S, et al. Malaria ecology along the Thailand-Myanmar border. Malar J. 2015;14:388.
37. Mishra SR, Dhimal M, Guinto RR, et al. Threats to malaria elimination in the Himalayas. Lancet Glob Health. 2016;4(8):e519.
38. Kaneko A, Taleo G, Kalkoa M, et al. Malaria eradication on islands. Lancet. 2000;356(9241):1560-4.
39. Kaneko A. A community-directed strategy for sustainable malaria elimination on islands: Short-term MDA integrated with ITNs and robust surveillance. Acta Trop 2010;114(3):177-83.